Clinical and biochemical characteristics of autoantibody systems in polymyositis and dermatomyositis.
نویسندگان
چکیده
P OLYMYOSITIS (PM) and dermatomyositis (DM) are inflammatory muscle diseases of unknown etiology. There is strong evidence for cellular immune mechanisms of muscle damage in these disorders. In recent years, numerous autoantibodies have been identified in patients with myositis, but their role in producing this clinical syndrome is unknown. In this report, we summarize the current state of knowledge about myositis-related autoantibodies, including characterization of the antigens, epidemiology, clinical significance. and the clues these autoantibodies may provide concerning the etiology and pathogenesis of the disease.
منابع مشابه
The clinical characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis.
We herein report the clinical and laboratory characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis (PM/DM). We compared these characteristics with previously published findings. Previous reports and our present cases show that anti-OJ autoantibody-positive interstitial lung disease (ILD) patient...
متن کاملSubcutaneous Emphysema, Pneumomediastinum and Pneumothorax in a Patient with Dermatomyositis
Introduction:Spontaneous pneumomediastinum, pneumothorax, and subcutaneous emphysema are rare, but serious complications of inflammatory myopathies and occur more commonly in DM than PM. complications of dermatomyositis (DM) and polymyositis (PM), both of which can be fatal. Case Report:A 20-year-old woman was admitted with neck pain, dyspnea, cough, and fever. She had been diagnosed with derma...
متن کاملMyositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
OBJECTIVE To analyze the prevalence of myositis-specific and myositis-associated autoantibodies and their clinical correlations in a large series of patients with dermatomyositis/polymyositis. METHOD This cross-sectional study enrolled 127 dermatomyositis cases and 95 polymyositis cases. The disease-related autoantibody profiles were determined using a commercially available blood testing kit...
متن کاملInterstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis.
OBJECTIVES To estimate the prevalence and predictors of interstitial lung disease in newly diagnosed polymyositis and dermatomyositis. METHODS A prospective study in which consecutive patients with newly diagnosed poly- and dermatomyositis, regardless of clinical symptoms of pulmonary disease, were investigated with chest x ray, high resolution computed tomography (HRCT), pulmonary function t...
متن کاملتاثیر درمان با گاماگلبولین وریدی در میوپاتیهای التهابی مقاوم به درمانهای رایج
The mainstay of pharmacologic therapy in patients with inflammatory myositis is corticosteroid and sometimes immunosuppressive drugs. However, because patients sometimes become refractory to these drugs and since these drugs have potential short and long-term toxicities, an alternate therapy is highly desirable. Therefore, a pilot study was initiated using intravenous gammaglobulin(IV...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Seminars in arthritis and rheumatism
دوره 15 4 شماره
صفحات -
تاریخ انتشار 1986